Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200057602Phase 4Not yet recruiting
Phase 4 trial of esketamine, fentanyl and propofol in procedural pain (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Incidence of hypoxemia. Planned start Mar 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200057602.